Chapter 594 Pediatric Stroke Syndromes
594.1 Arterial Ischemic Stroke (AIS)
In children the diagnosis of stroke is frequently delayed or missed. This is due to subtle and nonspecific clinical presentations, a complicated differential diagnosis (Chapter 594.4) and a lack of awareness by primary care pediatric physicians. The acute onset of a focal neurologic deficit in a child is stroke until proven otherwise. The most common focal presentation is hemiparesis but acute visual, speech, sensory, or balance deficits also occur. Children with these presentations require urgent neuroimaging and consultation with a child neurologist as emergency interventions may be indicated. AIS is a clinical and radiographic diagnosis. CT imaging can demonstrate larger mature AIS and exclude hemorrhage, however MRI identifies early and small infarcts and is therefore required to exclude ischemic stroke. Diffusion weighted MRI (DWI) can demonstrate AIS within minutes of onset, and MR angiography can confirm vascular occlusion and suggest arteriopathy as the underlying cause (Fig. 594-1).
Most etiologies for AIS are well-established; some represent only potential associations (Tables 594-1 and 594-2). AIS often remains idiopathic although most children have identifiable, frequently multiple risk factors. Three main categories of etiology should be considered: arteriopathic, cardiac, and hematological; full investigation often reveals multiple risk factors in a given individual.
MAJOR CATEGORY | EXAMPLES |
---|---|
Arteriopathic |
Table 594-2 MISCELLANEOUS AND GENETIC RISK FACTORS FOR STROKE
From Roach ES, Golomb MR, Adams R, et al: Management of stroke in infants and children, Stroke 39:2644–2691, 2008, Table 2, p 6.
HERNS, hereditary endotheliopathy with retinopathy, nephropathy, and stroke; MELAS, mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes; MERRF, myoclonic epilepsy with ragged red fibers.
Arteriopathy refers to disorders of the cerebral arteries and has emerged as the leading cause of childhood AIS, present in >50% of children. Idiopathic arterial stenosis has been termed focal cerebral arteriopathy (FCA), and may be more specfically identified as transient cerebral arteriopathy (TCA) or postvaricella angiopathy (PVA). These diseases likely represent focal, localized, unilateral vasculitis. More diffuse or bilateral vasculitis may be primary or associated with systemic inflammatory conditions (Table 594-3). Arterial dissection can be spontaneous or post-traumatic and can affect extracranial internal carotid or vertebral arteries, or intracranial arteries. Moyamoya disease may be idiopathic or associated with other conditions (NF-1, trisomy 21, sickle cell anemia, radiation therapy) and demonstrates progressive occlusion of the distal internal carotid arteries (Table 594-4, Fig. 594-2). Congenital malformations of the craniocervical arteries, including PHACES syndrome, may predispose to AIS.
From Roach ES, Golomb MR, Adams R, et al: Management of stroke in infants and children, Stroke 39:2644–2691, 2008, Table 5, p 8.
PATIENTS (n) | |
---|---|
No associated conditions (idiopathic) | 66 |
Neurofibromatosis type 1 | 16 |
Asian heritage | 16 |
Cranial therapeutic radiation | 15 |
Hypothalamic-optic system glioma | 8 |
Craniopharyngioma | 4 |
Medulloblastoma, with Gorlin syndrome | 1 |
Acute lymphocytic leukemia, intrathecal chemotherapy | 2 |
Down syndrome | 10 |
Congenital cardiac anomaly, previously operated | 7 |
Renal artery stenosis | 4 |
Hemoglobinopathy (2 sickle cell anemia, 1 “Bryn Mawr”) | 3 |
Other (hematologic: 1 spherocytosis, 1 idiopathic thrombocytopenic purpura) | 2 |
Giant cervicofacial hemangiomas | 3 |
Shunted hydrocephalus | 3 |
Idiopathic hypertension requiring medication | 3 |
Hyperthyroidism (1 with Graves syndrome) | 2 |
Other syndromes, 1 patient each: Reye (remote), Williams, Alagille, cloacal exstrophy, renal artery fibromuscular dysplasia, and congenital cytomegalic inclusion virus infection (remote). Two patients had unclassified syndromic presentations. There were 4 blacks, 2 of whom had sickle cell disease.
From Roach ES, Golomb MR, Adams R, et al: Management of stroke in infants and children, Stroke 39:2644–2691, 2008, Table 6, p 11.